India Globalization Cap (IGC)
0.3765
-0.01 -2.21%
NYSE MKT
Sep 22, 20:00
Delayed 2m
USD
View All Key Stats
IGC Key Stats
| Income Statement | |
| Revenue (TTM) | 0.5585M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.074 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -1.884M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 87.00% |
| Profit Margin (Quarterly) | -816.5% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0.00 |
| Price and Valuation | |
| Market Cap | 10.33M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 16.39 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 1.692 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.3874 |
| Free Cash Flow (Quarterly) | -0.5222M |
| Return on Equity (TTM) | -19.42% |
View All IGC News
IGC News
-
WireHeadlineTime (ET)
-
PR Newswire09/20 08:30
-
Globe Newswire09/18 08:00
-
Marketwired09/12 20:35
-
PR Newswire09/12 08:30
-
Globe Newswire09/11 08:00
-
SA Breaking News08/21 07:02
-
Globe Newswire08/21 07:00
-
Globe Newswire08/03 06:06
-
Yahoo08/01 09:57
-
Globe Newswire08/01 08:42
IGC Fundamentals
Income Statement View Statement
IGC Ratings
Advertisement
IGC One Page Reports
- One Page Report Download
IGC Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Target Price | |
| Price | 0.3765 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.igcinc.us
- Investor Relations URL: http://www.igcinc.us/investor-center/overview/
- HQ State/Province: Maryland
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Next Earnings Release: N/A
- Last Earnings Release: Aug. 17, 2016
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: India Globalization Capital Inc is engaged in the development of cannabis-based therapies to treat pain, PTSD, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions.
IGC Comparables
EditIGC Excel Add-In Codes
- Name: =YCI("IGC","name")
- Description: =YCI("IGC","description")
- Sector: =YCI("IGC","sector")
- Industry: =YCI("IGC","industry")
- Est. Current Fiscal Year End: =YCI("IGC","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other IGC Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- IGC Tweets Stocktwits
Advertisement
